FEI Tribunal issues Consent Award in equine anti-doping case

The FEI Tribunal has issued a Consent Award in an equine anti-doping case involving a Banned Substance.

In this case, the horse Eryn (FEI ID 105SX59/SUI), tested positive for Flufenamic acid, a banned substance, following samples taken at the CEI1*100 Oberstammheim (SUI) on 20 August, 2022.

The athlete, Melania Vanina (FEI ID 10160936/SUI), admitted the rule violation and accepted the consequences. The horse had been provisionally suspended for two months from the date of notification (26 September 2022 to 25 November 2022). 

In its final decision the FEI Tribunal disqualified the horse from the event and imposed an 18-month ineligibility period on the athlete; the provisional suspension she already served shall be credited against the imposed ineligibility period. She was also fined CHF 5,000.

The full Decision is available here.

Separately, the FEI has announced new adverse analytical findings (AAF) involving equine prohibited substances. The Endurance cases below involve *Banned Substances and in each case the athlete and trainer have been provisionally suspended. The horses have also been provisionally suspended for two months from the date of notification.

Case 2023/BS02:

Horse: Intruso Del Reparo (106GW63/BRN)

Person Responsible: Abrahim Alyahya (FEI ID 10204085/KSA)

Trainer: Khalifa Saad Sharida Mubarak (FEI ID 10043686/BRN)

Event: CEI1* 100 - Sakhir, Bahrain International Endurance Village (BRN), 08–10.12.2022

Prohibited Substance(s): Boldenone

Date of notification: 12 January 2023

 

Case 2023/BS01:

Horse: Zaime (106SS76/QAT)

Person Responsible: Mohd Jubal Ahmed Sayadur Rahman (FEI ID 10093895/QAT)

Trainer: Jassim Hilal H Abuhadoud (FEI ID 10030706/QAT)

Event: CEI1*100 - Doha, Mesaieed (QAT), 11–12.11.22

Prohibited Substance(s): 5α-estrane-3β, 17α-diol, Cobalt

Date of notification: 13 March 2023

 

Case 2023/BS03:

Horse: Hera Durances (106FU45/BRN)

Person Responsible: Abdulrahman Mohammed Alzayed (FEI ID 10026481/BRN)

Trainer: Muhammad Abbas Khalid (FEI ID 10220213/BRN)

Event: CH-M-E- Butheeb (UAE), 20-26.02.2023

Prohibited Substance(s): Stanozolol, 16-beta-hydroxystanozolol

Date of notification: 20 March 2023

 

Notes to Editors:

FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are medications that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.

In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.

Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.

FEI Clean Sport - human athletes

The FEI is part of the collaborative worldwide movement for doping-free sport led by the World Anti-Doping Agency (WADA). The aim of this movement is to protect fair competition as well as athlete health and welfare.

WADA’s Prohibited List identifies the substances and methods prohibited in- and out-of-competition, and in particular sports. The substances and methods on the List are classified by different categories (e.g., steroids, stimulants, gene doping).

As a WADA Code Signatory, the FEI runs a testing programme for human athletes based on WADA’s List of Prohibited List of Substances and Methods and on the Code-compliant FEI Anti-Doping Rules for Human Athletes (ADRHA).

For further information, please consult the Clean Sport section of the FEI website here.